$1.84
-0.08 (-4.17%)
Open$2.00
Previous Close$1.92
Day High$2.18
Day Low$1.72
52W High$31.50
52W Low$1.68
Volume—
Avg Volume324.6K
Market Cap28.61M
P/E Ratio0.02
EPS$149.76
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,897.3% upside
Current
$1.84
$1.84
Target
$36.75
$36.75
$26.33
$36.75 avg
$40.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 40.60M | 42.46M | 39.37M |
| Net Income | -1,409,045 | -1,565,662 | -1,719,749 |
| Profit Margin | -3.5% | -3.7% | -4.4% |
| EBITDA | -2,559,719 | -2,552,246 | -2,827,370 |
| Free Cash Flow | -1,137,405 | -963,691 | -1,418,550 |
| Rev Growth | +15.5% | -1.3% | +12.3% |
| Debt/Equity | 0.48 | 0.77 | 0.57 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |